Extemporaneous combination therapy with nebivolol/amlodipine for the treatment of hypertension: a real-world evidence study in Europe
Conclusions: The extemporaneous combination of nebivolol and amlodipine is commonly prescribed in Europe, however adherence to the therapy is poor. The development of a single-pill combination of nebivolol and amlodipine may improve adherence by reducing the number of pills administered to patients and thus simplifying treatment regimens.PMID:38459774 | DOI:10.1080/03007995.2024.2328652
Source: Current Medical Research and Opinion - Category: Research Authors: Giovambattista Desideri Riccardo Cipelli Valeria Pegoraro Claudio Ripellino Marco Miroddi Suada Meto Mario Gori Paolo Fabrizzi Source Type: research
More News: Databases & Libraries | France Health | Germany Health | Hungary Health | Hypertension | Italy Health | Norvasc | Poland Health | Research | Study